Document Detail


Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
MedLine Citation:
PMID:  22542954     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has recently been shown that the dopaminergic cell loss induced by neurotoxins is enhanced by brain angiotensin II (AII) via type 1 receptors (AT1). However, the mechanisms involved in the dopaminergic degeneration and the brain inflammatory effects of AII have not been clarified. The RhoA-Rho-Kinase (ROCK) pathway may play a critical role in the inflammatory and oxidative effects of AII. In the substantia nigra of mice, administration of the dopaminergic neurotoxin MPTP induced an increase in the expression of RhoA and ROCK II mRNA levels and ROCK activity, which were inhibited by AT1 receptor deletion (i.e., in AT1a null mice treated with MPTP). Administration of the ROCK inhibitor Y-27632 or AT1 deletion induced a significant decrease in MPTP-induced microglial activation and dopaminergic cell death. In rat primary mesencephalic cultures treated with MPP(+), the increase in dopaminergic cell loss induced by AII administration was also inhibited by treatment with Y27632. Intense expression of ROCK II was observed in the microglial cells in the substantia nigra of mice treated with MPTP, and the major role of the microglial ROCK was confirmed by comparing mesencephalic cultures with and without microglia. Activation of the RhoA/ROCK pathway is involved in the MPTP-induced dopaminergic degeneration, and in the enhancing effect of AII/AT1 activation on the microglial response and dopaminergic degeneration. ROCK inhibitors and AT1 receptor antagonists may provide new neuroprotective strategies against the progression of Parkinson's disease.
Authors:
Begoña Villar-Cheda; Antonio Dominguez-Meijide; Belen Joglar; Ana I Rodriguez-Perez; Maria J Guerra; Jose L Labandeira-Garcia
Related Documents :
17767394 - Orphan g-protein-coupled receptors : strategies for identifying ligands and potential f...
22510304 - Endocannabinoids modulate nanc inhibitory neurotransmission in strips from the mouse ga...
9013884 - The c-terminal domain of the gs-coupled ep4 receptor confers agonist-dependent coupling...
22309794 - Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethylti...
12676344 - Chronic treatment with ionotropic glutamate receptor antagonist kynurenate affects gaba...
12570724 - Studies on human neutrophil biological functions by means of formyl-peptide receptor ag...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-04-19
Journal Detail:
Title:  Neurobiology of disease     Volume:  47     ISSN:  1095-953X     ISO Abbreviation:  Neurobiol. Dis.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-06-04     Completed Date:  2013-04-03     Revised Date:  2013-04-24    
Medline Journal Info:
Nlm Unique ID:  9500169     Medline TA:  Neurobiol Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  268-79     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Affiliation:
Department of Morphological Sciences, Faculty of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amides / pharmacology,  therapeutic use
Angiotensins / physiology*
Animals
Cell Death / drug effects,  physiology
Cells, Cultured
Dopaminergic Neurons / enzymology,  metabolism*,  pathology
Enzyme Inhibitors / pharmacology,  therapeutic use
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Microglia / enzymology,  metabolism*,  pathology
Parkinson Disease / physiopathology,  prevention & control
Pyridines / pharmacology,  therapeutic use
Receptor, Angiotensin, Type 1 / physiology*
Signal Transduction / physiology*
rho GTP-Binding Proteins / physiology*
rho-Associated Kinases / antagonists & inhibitors,  physiology
Chemical
Reg. No./Substance:
0/Amides; 0/Angiotensins; 0/Enzyme Inhibitors; 0/Pyridines; 0/Receptor, Angiotensin, Type 1; 138381-45-0/Y 27632; EC 2.7.11.1/rho-Associated Kinases; EC 3.6.5.2/RhoA protein, mouse; EC 3.6.5.2/rho GTP-Binding Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Loudness dependence of auditory evoked potentials in patients with borderline personality disorder-I...
Next Document:  Are Ambient Ultrafine, Accumulation Mode, and Fine Particles Associated With Adverse Cardiac Respons...